Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Drug ineffective, Nasopharyngitis, SARS-CoV-2 test
Clinical narrative: had covid, both tests came back positive,sick; Lack of drug effect; cold; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (had covid, both tests came back positive,sick), DRUG INEFFECTIVE (Lack of drug effect) and NASOPHARYNGITIS (cold) in a 55-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 036B21A and 037A21B) for COVID-19 vaccination.     No Medical History information was reported.   On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In 2021, the patient experienced NASOPHARYNGITIS (cold). In August 2021, the patient experienced COVID-19 (had covid, both tests came back positive,sick) and DRUG INEFFECTIVE (Lack of drug effect). At the time of the report, COVID-19 (had covid, both tests came back positive,sick), DRUG INEFFECTIVE (Lack of drug effect) and NASOPHARYNGITIS (cold) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In August 2021, SARS-CoV-2 test: positive (Positive) positive.         He got Covid-19 positive along with his wife and daughter at the same time in August.  No concomitant and treatment information were provided.  Company comment: This case concerns a 55-years-old male patient, with no medical history reported in this case, who experienced the non-serious AESI of COVID-19. Additionally, Drug ineffective was also reported. The events were reported to occur approximately 4 months after the administration of the second dose of a proper schedule of vaccination with the mRNA-1273 vaccine (29 days between doses).  Further information received states that the patient had cold symptoms and no hospitalization was required.  No further information was disclosed.  The rechallenge is not applicable as the events occurred after the administration of the second dose of the mRNA-1273 vaccine.  The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.   This case was linked to MOD-2021-415978 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 15-Dec-2021: Follow up information contains reporter details, patient demographics and event details added.; Sender's Comments: This case concerns a 55-years-old male patient, with no medical history reported in this case, who experienced the non-serious AESI of COVID-19. Additionally, Drug ineffective was also reported. The events were reported to occur approximately 4 months after the administration of the second dose of a proper schedule of vaccination with the mRNA-1273 vaccine (29 days between doses).  Further information received states that the patient had cold symptoms and no hospitalization was required.  No further information was disclosed.  The rechallenge is not applicable as the events occurred after the administration of the second dose of the mRNA-1273 vaccine.  The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.